Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.900
-0.060 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Qualigen Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 0.39 | 0.4 | 3.17 | 17.54 | 23.98 | 0.15 | Upgrade
|
Cash & Short-Term Investments | 0.39 | 0.4 | 3.17 | 17.54 | 23.98 | 0.15 | Upgrade
|
Cash Growth | -81.28% | -87.31% | -81.95% | -26.85% | 15558.58% | 22.38% | Upgrade
|
Receivables | 1.3 | - | - | 0.82 | 0.62 | 0.71 | Upgrade
|
Inventory | - | - | - | 1.06 | 0.95 | 0.66 | Upgrade
|
Prepaid Expenses | 0.63 | 0.76 | 1.37 | 1.38 | 2.68 | 0.1 | Upgrade
|
Other Current Assets | - | - | 6.29 | 0 | - | - | Upgrade
|
Total Current Assets | 2.31 | 1.17 | 10.82 | 20.8 | 28.22 | 1.62 | Upgrade
|
Property, Plant & Equipment | - | - | 0.03 | 1.85 | 0.7 | 1.51 | Upgrade
|
Other Intangible Assets | - | - | - | 0.17 | 0.19 | 0.57 | Upgrade
|
Other Long-Term Assets | - | 0.87 | 8.24 | 0.02 | 0.02 | 0.02 | Upgrade
|
Total Assets | 2.31 | 2.03 | 19.08 | 22.84 | 29.13 | 3.72 | Upgrade
|
Accounts Payable | 1.64 | 2.22 | 0.62 | 0.89 | 0.5 | 0.88 | Upgrade
|
Accrued Expenses | 0.56 | 0.55 | 0.85 | 1.46 | 0.58 | 1.1 | Upgrade
|
Short-Term Debt | 1.43 | 1.3 | 0.06 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.13 | 1.91 | Upgrade
|
Current Portion of Leases | - | - | - | 0.13 | 0.25 | - | Upgrade
|
Current Income Taxes Payable | - | - | - | 0 | 0 | 0.01 | Upgrade
|
Current Unearned Revenue | - | - | - | 0.14 | 0.49 | 0.38 | Upgrade
|
Other Current Liabilities | 0.82 | 0.06 | 7.07 | 2.01 | 8.47 | 1.06 | Upgrade
|
Total Current Liabilities | 4.45 | 4.14 | 8.61 | 4.64 | 10.43 | 5.34 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.01 | 0.31 | Upgrade
|
Long-Term Leases | - | - | - | 1.54 | 0.24 | - | Upgrade
|
Long-Term Unearned Revenue | - | - | - | 0.09 | 0.16 | 0 | Upgrade
|
Other Long-Term Liabilities | - | - | 1.71 | - | - | - | Upgrade
|
Total Liabilities | 4.45 | 4.14 | 10.32 | 6.27 | 10.83 | 5.65 | Upgrade
|
Common Stock | 0.07 | 0.04 | 0.04 | 0.04 | 0.03 | 0.06 | Upgrade
|
Additional Paid-In Capital | 120 | 114.66 | 110.53 | 101.27 | 85.11 | 45.16 | Upgrade
|
Retained Earnings | -122.21 | -116.8 | -103.39 | -84.74 | -66.85 | -47.3 | Upgrade
|
Comprehensive Income & Other | - | - | 0.05 | - | - | - | Upgrade
|
Total Common Equity | -2.14 | -2.1 | 7.24 | 16.56 | 18.29 | -2.08 | Upgrade
|
Minority Interest | - | - | 1.53 | - | - | - | Upgrade
|
Shareholders' Equity | -2.14 | -2.1 | 8.77 | 16.56 | 18.29 | -1.93 | Upgrade
|
Total Liabilities & Equity | 2.31 | 2.03 | 19.08 | 22.84 | 29.13 | 3.72 | Upgrade
|
Total Debt | 1.43 | 1.3 | 0.06 | 1.68 | 0.63 | 2.22 | Upgrade
|
Net Cash (Debt) | -1.05 | -0.9 | 3.11 | 15.86 | 23.35 | -2.07 | Upgrade
|
Net Cash Growth | - | - | -80.42% | -32.06% | - | - | Upgrade
|
Net Cash Per Share | -5.47 | -8.85 | 40.44 | 270.35 | 806.49 | -184.39 | Upgrade
|
Filing Date Shares Outstanding | 0.74 | 0.13 | 0.1 | 0.07 | 0.06 | 0.01 | Upgrade
|
Total Common Shares Outstanding | 0.55 | 0.11 | 0.08 | 0.07 | 0.05 | 0.01 | Upgrade
|
Working Capital | -2.14 | -2.97 | 2.21 | 16.16 | 17.79 | -3.72 | Upgrade
|
Book Value Per Share | -3.90 | -19.61 | 85.92 | 234.69 | 335.11 | -185.96 | Upgrade
|
Tangible Book Value | -2.14 | -2.1 | 7.24 | 16.39 | 18.11 | -2.65 | Upgrade
|
Tangible Book Value Per Share | -3.90 | -19.61 | 85.92 | 232.27 | 331.68 | -236.95 | Upgrade
|
Machinery | - | - | - | 4.41 | 3.26 | 3.24 | Upgrade
|
Construction In Progress | - | - | - | - | 0.1 | 1.38 | Upgrade
|
Leasehold Improvements | - | - | - | 0.33 | 0.32 | 0.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.